Syria achieves polio milestone

2 years without a reported case

A young boy has his finger marked after polio vaccination
A young boy has his finger marked after polio vaccination WHO/EMRO

23 January 2016 – Syria is approaching 2 years without a reported case of polio today despite enormous challenges adversely affecting the delivery of health services, including childhood vaccinations.

Polio resurged in Syria in October 2013 after 14 years of absence, following a sharp drop in immunization coverage and importation of wild poliovirus.  35 cases were reported in 2013 (25 in Deir ez-Zor, 5 in Aleppo, 3 in Idleb, 2 in Al-Hassakeh) and 1 in Hama in January 2014. Transmission was halted after a series of mass vaccination campaigns held across the country reaching more than 2.9 million children under 5 years of age with repeat doses of oral polio vaccine (OPV).

“I am pleased and impressed that Syria has maintained a zero polio status for the past 2 years, given its current crisis context,” said Ms Elizabeth Hoff, WHO Representative to Syria. “This is a testament to the dedication and grit of Syrian health workers. Remember, the country is still at high risk of polio, and to keep Syria polio-free we must continue to carry out vaccination campaigns to increase immunity, focusing particularly on children in hard-to-reach areas,” she said. “We must also continue to strengthen disease surveillance systems to monitor for polio. We need to be prepared if the virus resurfaces,” she added.

“This is a major milestone for Syria,” said Hanaa Singer, UNICEF Representative in Syria. “We pay tribute to all health workers and volunteers who made this possible.  We must grant them further protection and champion their efforts to reach every child, everywhere across Syria, particularly in hard-to-reach areas. Maintaining these gains remains of paramount importance.”

Read full statement

Related


Related News

   25/06/2019
Reaching underserved populations with immunization in the Niger Delta
   21/06/2019
Everyday people in Pakistan advocating for vaccinations
   11/06/2019
Polioviruses will be kept after eradication in a limited number of laboratories and vaccine manufacturing facilities worldwide. Containment of these viruses will be critical to maintaining a polio-free world.
   11/06/2019
Public health legend and head of the Containment Advisory Group Professor David Heymann talks about some of the similarities and differences between poliovirus and smallpox containment, and work of the CAG.
   06/06/2019
Ticky Esoh Ebongue, Business Analysist for Polio Eradication at WHO in Geneva, speaks to us about the importance of transparent and accountable financial management, which helps both donors and countries in their strategic planning.
   05/06/2019
WHO supports the Democratic Republic of the Congo (DR Congo) in managing live type 2 polio vaccine in the field